Digital Health in Pharma Research – Introduction

Digital Health in Pharma Research is Galen Growth’s latest insights report. Firstly, we explore the boundaries of Pharma Research. Secondly, we explain the current trends. Overall, our analysis focuses on private ventures and start-ups. In summary, the report includes noteworthy partnerships, spotlight ventures, and venture funding. HealthTech Alpha, a Galen Growth proprietary solution, powers this report!

Digital Health in Pharma Research – Key Insights

Some key insights from the report that will be highlighted:

  • R&D productivity is down, costs are up, and drug prices are under scrutiny. As a result, the drug discovery process needs new and innovative ideas,
  • Large Pharma companies remain undeterred by these challenges. Hence, have set themselves challenging goals,
  • The top 20 Pharma companies (by revenue) have entered into an average of 12 partnerships each with Digital Health ventures,
  • Within Digital Health, Research Solutions is a small cluster,
  • North America dominates the landscape by hosting 39% of the ventures,
  • Future progress in Digital Health tools for Research will hinge on addressing data privacy concerns and more.

Read our free executive summary for more information here.

Source of Data

HealthTech Alpha, Galen Growth’s proprietary on-demand platform, is the data source for this report. HealthTech Alpha contains more than 170 million data points and hence is the leading Digital Health intelligence and analytics platform! Moreover, its coverage exceeds 11,500 Digital Health ventures globally. To find out more about our data, visit, or visit for our reports.

Our Mission

Founded by HealthTech innovators, Galen Growth solves global healthcare system pain points and to create significant financial and social values. To find out more, visit

About our Premium Reports

Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.

Source of Data

Galen Growth’s proprietary platform, HealthTech Alpha, provides the data source for this report. Corporate Business Development, Business Intelligence, and Digital Health Partnership teams worldwide prefer HealthTech Alpha, the world’s most-trusted Digital Health data, intel, and insights platform. Visit to learn more about our data or research for our reports.

Our Mission

Founded in 2016 by Digital Health experts, Galen Growth empowers global Fortune 500 companies, institutional investors, and promising Digital Health ventures to fast track their digital health strategy to create significant financial and social values. To find out more, visit

Buy Only


  • Purchase and download this report
  • Access to limited data in HealthTech Alpha
Buy Now


  • Sign up now to download all premium research
  • Access and download all data in HealthTech Alpha
$ 385 /Month
Custom Solution


  • Get full access to unmatched premium research for your organization
  • Additional collaboration features to take your team's research and collaboration to the next level
Let's Talk
Contact Us

© Galen Growth 2024




Total Funding

GGA Score

powered by